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http://dx.doi.org/10.1016/j.bpj.2014.07.054Voltage-sensitive dyes provide a way to observe cellular
electrical activity without the physical limitations imposed
by electrodes. Although these dyes can monitor membrane
potential with a resolution of a few microns from large
populations of cells (1), there are three obstacles that pre-
vent the use of these dyes in many research settings,
including clinical research:
1. Most voltage-sensitive dyes use visible wavelengths of
light that prevent imaging of tissues beneath the skin.
2. Many of these dyes produce significant toxicity or off-
target effects (2).
3. Before this report, to our knowledge, no voltage-sensi-
tive dyes have ever been available for administration in
humans, which has limited their value in biomedically
focused research.
Here, we show that indocyanine green (ICG), an FDA-
approved fluorescent dye routinely used in many clinical
tests, is voltage-sensitive. Our initial experimental system
used Xenopus laevis oocytes. Changes in the membrane po-
tential of the cell induced by two-electrode voltage-clamp
resulted in robust, consistent changes in the fluorescence
of ICG (Fig. 1, inset). All data in this work was obtained
from single acquisitions with no averaging of multiple
images. The voltage-dependent fluorescence changes were
roughly linear with respect to membrane potential and had
a magnitude of ~1.9% of the baseline fluorescence per
100 mV of membrane potential change (Fig. 1). Addition-ally, ICG displayed a rapid response with a primary time
constant of 4 ms (see Fig. S1 in the Supporting Material),
suggesting that this dye could successfully monitor action
potentials.
To test this hypothesis, we transformed our oocytes into
synthetic neurons, previously dubbed ‘‘excitocytes’’, by
coinjecting them with cRNA of voltage-gated sodium
(Nav) and potassium channel components (3). Under suit-
able current-clamp conditions, excitocytes fire trains of
action potentials similar to those in naturally excitable cells.
ICG’s fluorescence clearly recapitulated action potentials
firing at speeds above 100 Hz (Fig. 2 A), faster than the
physiological firing rates of most neurons (4).
We extended the excitocyte technique from wild-type
channels to evaluation of channelopathies and their effects
on excitability to determine whether ICG could discriminate
between normal and diseased action potentials based on
shape. We compared excitocytes injected with wild-type
Nav channel cRNA to those injected with cRNA coding
for a version of Nav channel containing a point mutation,
G1306E, which produces episodic myotonia (5). This dis-
ease is characterized by continued action potential firing
in skeletal muscles after cessation of voluntary stimuli;
FIGURE 1 ICG-labeled oocytes showed that ICG’s fluores-
cence (blue points) is roughly linearly dependent (red line, fit
to data) with voltage. (Inset) Oocyte membrane potential was
held at 60 mV and then pulsed to potentials ranging from
120 mV (blue) toD120 mV (red). Ex: 780 nm, Em: 818–873 nm.
FIGURE 2 ICG can monitor action potentials. (A) Oocytes coin-
jected with voltage-gated sodium and potassium channel cRNA
fired action potentials (bottom, green) when held under current
clamp. ICG fluorescence changes (top, blue) detected these
action potentials at a rate of 107 Hz. Stimulus start (black arrow)
and end (red arrow) are shown. (B and C) ICG fluorescence
(blue, inverted) distinguished between healthy action potentials
from wild-type sodium channels (B, green) and diseased action
potentials from sodium channels with a myotonic substitution
(C, green). Cells are stimulated for the entire time course of
these panels. The delay between action potentials and the ICG
signal is due to a low-pass filtering effect caused by the dye
response time and the camera integration time. (D) In cells
with myotonic sodium channels, a brief stimulus (top, black)
was sufficient to elicit a train of action potentials (bottom, green)
that only ceased upon significant hyperpolarization, as ex-
pected in a myotonia. ICG fluorescence (middle, blue) success-
fully followed each one of these action potentials.
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mark of myotonia. Compared to the wild-type Nav channel,
the G1306E mutation causes a slowing of the fast inactiva-
tion of the Nav channels, which in turn results in broadened
action potentials (5). The electrical recordings and the ICG
fluorescence response clearly distinguished the sharp action
potentials produced by the healthy sodium channel (Fig. 2
B, and see Fig. S2) from the wider peaks produced by the
myotonic sodium channel (Fig. 2 C, and see Fig. S2).
Furthermore, a brief injection of current led to repetitive
firing and hyperexcitability that persisted after the stimulus
was stopped. ICG fluorescence clearly resolved every action
potential of this myotonia-like behavior (Fig. 2 D). The suc-
cessful recreation of disease-like action potentials validates
the excitocyte system as a convenient method for investi-
gating the electrophysiological effects of channelopathies.
We next investigated whether ICG’s voltage sensitivity
extended to excitable mammalian tissue. This validation
was critical, inasmuch as other voltage-sensitive dyes have
shown promise in invertebrate preparations but had much
smaller signals in mammalian cells (6). We first measured
ICG fluorescence from cultured rat dorsal root ganglion
neurons. Under whole-cell current clamp, we observed neu-
rons firing in the stereotypical fashion of the nociceptive
C-type fiber, and these action potentials were clearly visible
in the ICG fluorescence (Fig. 3 A, and see Fig. S3). We
also examined syncytia of cultured cardiomyocytes from
neonatal rats (7) to further validate ICG’s utility; these
cells beat spontaneously and showed changes in ICG fluo-
rescence indicative of changes in membrane potential
(Fig. 3 B). Although we cannot formally exclude the possi-
bility that the cardiomyocytes’ physical motion produced
fluorescence changes, several observations suggested that
these effects were minimal (see Fig. S4). Taken together,Biophysical Journal 107(6) L9–L12our results in frog and rat cells confirmed that ICG voltage
sensitivity was broadly applicable across a range of tissues
and not confined to a particular animal or cell lineage.
Finally, we tested whether ICG voltage sensitivity could
be detected in a complex tissue. Rat hippocampal slice cul-
tures comprise a well-described organotypic preparation in
which the three-dimensional architecture, neuronal connec-
tions, and glial interactions are maintained (8,9). Using
these rat brain explants, we found that brain excitation
FIGURE 3 ICG follows electrical activity in living mammalian
tissue. (A) Rat cultured dorsal root ganglion cells under cur-
rent-clamp (black arrow, pulse start; red arrow, pulse end) fired
action potentials (green), that ICG fluorescence tracked (blue,
inverted, low-pass-filtered at 225 Hz; blue arrow, relative fluores-
cence change). (B) ICG fluorescence sensed spontaneousmem-
brane potential changes in cardiomyocyte syncytia. (C) In rat
brain slices, ICG responds differently to no stimulus (black)
and stimuli of increasing intensity (magenta, cyan, green, and
blue, increasing amplitude; scale bar shows relative fluores-
cence change). Weaker stimuli traces (e.g.,magenta) show com-
plete fluorescence recovery whereas larger stimuli (e.g., blue)
do not fully recover within this time course; traces are vertically
offset for clarity. (D) Tetrodotoxin (TTX) reduced the ICG
response to a stimulus over 12 min (green, pre-TTX; cyan,
magenta, and black, increasing time post-TTX; low-pass-filtered
at 40 Hz; black arrow, stimulus).
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panied by ICG fluorescence changes (see Fig. S5). Addi-
tionally, ICG discriminated between electrical responses
caused by differing excitation intensities and durations
(Fig. 3 C, and see Fig. S5). To confirm that the fluorescence
changes originated from changes in excitable cell activity,
we used the Nav channel blocker tetrodotoxin (TTX).
When applied to brain slices, electrical excitability was
clearly inhibited (Fig. 3 D, and see Fig. S5) and partial re-
covery was observed upon subsequent TTX removal (see
Fig. S5). These signals measuring brain slice activity were
similar in shape and magnitude to those reported using other
voltage-sensitive dyes (10,11). This demonstrates that ICG
can report on electrical activity even in a physiological ar-
chitecture with many nonexcitable cells.
To our knowledge, this is the first report that a clinically
approved fluorescent dye is voltage-sensitive. Our results
demonstrate that indocyanine green can accurately detect
action potentials at firing rates common in mammalian neu-rons, and that it is sensitive enough to distinguish between
healthy and diseased action potentials in a model system.
ICG can measure electrical activity in mammalian neurons,
cardiomyocytes, and explanted brain tissue. This voltage
sensitivity was observed with both monochromatic and
broad-band illumination sources (data not shown), under
labeling conditions that differed in solution composition,
duration, and dye concentration (see Methods in the Sup-
porting Material), and at temperatures ranging from 19C
to 30C. ICG’s water solubility further extends its potential
utility. This robustness suggests that ICG can be used to
measure voltage in many environments and tissues.
ICG has been FDA-approved for use in ophthalmic angi-
ography, as well as in tests of cardiac output and hepatic
function (12) and is additionally used off-label in a number
of surgical applications (13). Interestingly, ICG has been
shown to clearly label retinal ganglion cells in human pa-
tients (see Fig. S6) (14). This provides immediate moti-
vation for biomedical investigations, because laboratory
findings with ICG can potentially be translated to humans.
Although many other voltage-sensitive dyes have been
described, some with similar structures to ICG (15) and
others with faster or larger signals (15,16), as of this writing
none of these are FDA-approved. Additionally, ICG utilizes
wavelengths further into the infrared spectrum than other
available fast potentiometric dyes (17) and can thus be
imaged in tissues up to 2 cm deep (18). This presents the
possibility of optically imaging electrical activity deeper in-
side tissues than is feasible today. Although two-photon
excitation with voltage-sensitive dyes can improve imaging
depth, it remains intrinsically limited by the unaffected
emission wavelength (19). Finally, ICG has been used in
patients for more than 50 years and is known to have low
toxicity (18,20). These properties suggest that ICG voltage
sensitivity could extend the capabilities of modern
electrophysiological techniques for disease diagnosis and
monitoring in the clinic, and allow for the investigation
of previously inaccessible experimental systems in basic
research.SUPPORTING MATERIAL
Six figures, supporting methods, and data analysis are available at http://
www.biophysj.org/biophysj/supplemental/S0006-3495(14)00801-7.
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